Official NIH NLM MEDLINE / PubMed Citation • PMID: 42579565
suPAR Identifies Treatment-Resistant Inflammatory Risk Beyond hs-CRP in Type 2 Diabetes With Coronary Artery Disease: An Ancillary Analysis of BARI 2D.
Diabetes Care
Verbatim Formal Study Abstract
Over 1 year, suPAR was not reduced by diabetes (insulin sensitizing vs.